NCT01023542View on ClinicalTrials.gov

"CNI-free Bottom-up Immunosuppression in Patients Undergoing Liver Transplantation"

PHASE2/PHASE3UnknownINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

December 31, 2014

Conditions

Renal ImpairmentLiver TransplantationEverolimus

Interventions

DRUG

delayed, low-dose CNI

immunosuppression

DRUG

BU-CNI

Immunosuppression

DRUG

BU-Everolimus

Immunosuppression

Trial Locations (1)

93053

RECRUITING

Regensburg University Hospital, Regensburg

Sponsors

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

University of Regensburg

OTHER